Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Spontaneous thrombosis of an orbital arteriovenous malformation revealing hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). A case report.
Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice.
Spatial price equilibrium networks with flow-dependent arc multipliers.
Revisiting dietary proanthocyanidins on blood glucose homeostasis from a multi-scale structural perspective.
The safety of rosiglitazone in the treatment of type 2 diabetes.
See All 29 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S, Loke YK. The safety of rosiglitazone in the treatment of type 2 diabetes. Expert Opin Drug Saf. 2008 Sep; 7(5):579-85.
View in:
PubMed
subject areas
Blood Glucose
Cardiovascular Diseases
Clinical Trials as Topic
Diabetes Mellitus, Type 2
Fractures, Bone
Heart Failure
Humans
Hypoglycemic Agents
Myocardial Infarction
Risk Factors
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH